scholarly journals The MEK1/2 inhibitor, selumetinib (AZD6244; ARRY-142886), enhances anti-tumour efficacy when combined with conventional chemotherapeutic agents in human tumour xenograft models

2012 ◽  
Vol 106 (5) ◽  
pp. 858-866 ◽  
Author(s):  
S V Holt ◽  
A Logié ◽  
R Odedra ◽  
A Heier ◽  
S P Heaton ◽  
...  
Keyword(s):  
Chemotherapeutic Agents ◽  
Human Tumour ◽  
Human Tumour Xenograft ◽  
Tumour Xenograft ◽  
Xenograft Models

scholarly journals The use of thermographic imaging to evaluate therapeutic response in human tumour xenograft models

2016 ◽  
Vol 6 (1) ◽  
Author(s):  
Nosheen Hussain ◽  
David Connah ◽  
Hassan Ugail ◽  
Patricia A. Cooper ◽  
Robert A. Falconer ◽  
...  
Keyword(s):  
Therapeutic Response ◽  
Human Tumour ◽  
Human Tumour Xenograft ◽  
Tumour Xenograft ◽  
Thermographic Imaging ◽  
Xenograft Models

scholarly journals Response of a high-glucuronidase human tumour xenograft to aniline mustard

1982 ◽  
Vol 45 (1) ◽  
pp. 27-34 ◽  
Author(s):  
H M Warenius ◽  
P Workman ◽  
N M Bleehen
Keyword(s):  
Human Tumour ◽  
Human Tumour Xenograft ◽  
Tumour Xenograft

scholarly journals Influence of tumour size on uptake of111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model

2000 ◽  
Vol 83 (5) ◽  
pp. 684-688 ◽  
Author(s):  
K J Harrington ◽  
G Rowlinson-Busza ◽  
K N Syrigos ◽  
R M Abra ◽  
P S Uster ◽  
...  
Keyword(s):  
Tumour Size ◽  
Xenograft Model ◽  
Human Tumour ◽  
Pegylated Liposomes ◽  
Human Tumour Xenograft ◽  
Tumour Xenograft ◽  
Tumour Xenograft Model
Sign in / Sign up

Export Citation Format

Share Document